Zenith Health Care P/E Ratio
Current P/E Ratio
350.0
High Valuation
Very High - High growth expectations or significantly overvalued
Zenith Health Care (ZENITHHE) P/E ratio is 350.0 (High), EPS (TTM) ₹0.01, current price ₹3.50 on BSE — Very High - High growth expectations or significantly overvalued. Read ZENITHHE dividend track record for the complete payout history and dividend yield track record.
Current Valuation Metrics
P/E Ratio
350.0
Current Price
₹3.50
EPS (TTM)
₹0.01
Exchange
BSE
Valuation Signal
Signal
Overvalued
Sector Context
Sector Average
55.3
Sector Median
31.33
Sector Rank
#11 of 195
Sector Percentile
5.6%
ZENITHHE P/E Ratio — Valuation Signal & Historical Context
Zenith Health Care P/E 350.0 — signal: Overvalued. For live price, revenue and the complete fundamental profile, see Zenith Health Care screener.
- Stock appears overvalued with PE of 350.0, suggesting caution for new investments
- Trading at premium to sector average PE of 55.3
ZENITHHE vs Healthcare Peers — P/E Ratio Comparison
Zenith Health Care P/E 350.0 vs Healthcare average 55.3, median 31.33 — range 2.86–916.67.
Sector Average
55.3
Sector Median
31.33
Lowest P/E
2.86
Highest P/E
916.67
Companies
195
| Company | Symbol | P/E Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Murae Organisor | MURAE | 2.86 | ₹41 | Low |
| Phaarmasia | PHRMASI | 3.61 | ₹64 | Low |
| Sunrest Lifescience | SUNREST | 3.82 | ₹31 | Low |
| Sun Pharma Advanced Rese… | SPARC | 4.76 | ₹7,399 | Low |
| Shelter Pharma | SHELTER | 5.23 | ₹47 | Low |
| Dipna Pharmachem | DPL | 5.39 | ₹14 | Low |
| JFL Life Sciences | JFLLIFE | 5.46 | ₹72 | Low |
| Mono Pharmacare | MONOPHARMA | 5.82 | ₹18 | Low |
| Amwill Health Care | AMWILL | 7.15 | ₹82 | Low |
| Zenith Drugs | ZENITHDRUG | 7.69 | ₹90 | Low |